| Home | Free Articles for Your Site | Submit an Article | Advertise | Link to Us | Search | Contact Us |
This site is an archive of old articles


vertical line

Acomplia: The Search for Anti-Obesity Drug Ends Here


Anti-obesity drugs are the prime requirement of millions of obese across the world. Only an obese knows well about the problem related with obesity. Every third person tries to instruct an obese what to eat and what not to. There are people who laugh at an obese. Every obese knows that obesity can be cured with the help of suppression of appetite and proper exercising. Both things are easy to suggest but difficult to do. Exercising needs time and where is the time in the busy schedule to do rigorous exercising? How can an obese suppress appetite when urge for food is acute?

Appetite can be effectively suppressed with the aid of appetite suppressing drugs. The list of such drugs is long but most of them are in the weight loss drug market for years and obesity is still there. This puts a big question mark on the efficacy of those appetite suppressants. Recently, Sanofi-Aventis a drug manufacturing company of France has launched a new medication in the European anti-obesity drug market.

This drug is introduced by name of Acomplia and was initially launched in the UK drug market where countless obese found it very effective. Acomplia is a product of advance drug development technology whose line action of is quiet different from almost all anti-obesity medication available in the market. Cells of our body have neurotic receptors named as cannaboid receptor-1; this receptor is responsible for the transmission of hunger signal to the brain. The substance, which can block the working of CB-1 receptor, can be a proven appetite suppressant. Acomplia’s active ingredient Rimonabant does this work. Acomplia can also help in the cessation of smoking by inhibiting the working of the CB-1 receptor.

Acomplia is an oral prescription medication, which should be taken only on doctor’s advice. Generally doctors prescribe 20mg pills of Acomplia, which should be taken with one glassful of water. This medication produces better results when it is taken on empty stomach that is the reason why most doctors suggest for taking the pill an hour before breakfast. Breaking of Acomplia pills can produce some unnecessary changes in chemical structure of the medication so it must not be chewed.

It is the popularity of the medication that some unknown company has introduced a drug by the Acomplix in the weight loss drug market. But user of Acomplia should be aware of such duplicate and ineffective copies of this powerful medication as they may cause some harms.

The Acomplia drug may have some mild side effects like dizziness, constipation, nausea, dry mouth and stomach disorder. The side effects are limited to the use of drug for initial period only because of non-adjustment of the body to the medication. Generally side effects disappear with the regular use of this beneficial medication for few days. Acomplia is not meant for the pregnant ladies and breast-feeding mothers.

Acomplia is easily available through an online order; the delivery of product is made at your doorstep.

Submitted by:

Jack White

Jack White is an associated editor to AcompliaRimonabant. He is a contributing author and provides information on General Health related issues. For more details related to Acomplia rimonabant, Xenical, Reductil, Acomplia Diet Pill, Lipograsil, Slim 24, weight loss drug, Turbo Slim Men visit http://www.acompliarimonabant.co.uk.





ARTICLE CATEGORIES

Auto and Trucks
Business and Finance
Computers and Internet
Education
Family
Finances
Food and Drink
Gadgets and Gizmos
Health
Hobbies
Home Improvement
Humor
Kids and Teens
Legal
Marketing
Men
Music and Movies
Online Business
Parenting
Pets and Animals
Politics and Government
Recreation and Sports
Relationships
Religion and Faith
Self Improvement
Site Promotion
Travel and Leisure
Web Development
Women
Writing



http://www.articlesurfing.org/health/acomplia_the_search_for_antiobesity_drug_ends_here.html
Copyright © 1995-2016 Photius Coutsoukis (All Rights Reserved).